V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Insulet Executive Compensation (FY25)

PODD · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (8-K): May 21, 2026
389 figures on this page: 378 cited to the filing that reported them, 11 calculated from figures it prints. See the citations
Ashley McEvoy, President and Chief Executive Officer, received $18,858,968 in total compensation for fiscal 2025, and for fiscal 2025, the company reported 8 named executive officers. Separately, for fiscal 2025, the company reported a chief executive pay ratio of 213:1; the say-on-pay proposal drew 92.0% of votes cast for or against in favor at the meeting held May 20, 2026 for fiscal 2025. The disclosed peer group names Align Technology, Inc., Aspen Technology, Inc., Bio-Techne Corporation, DexCom, Inc. and Exact Sciences Corporation, among others.
Chief executive, fiscal 2025
◇
Ashley McEvoy
Median of the other named officers
$4,404,259
7 officers, excluding the chief executive
Latest say-on-pay support
=
May 20, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: James Hollingshead → Ashley McEvoy
Say-on-pay support: 93.2% → 92.0% (1.2 points lower)
CEO pay ratio: 137:1 → 213:1 (55.5% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Insulet's chief executive and what were they paid?
Ashley McEvoy, President and Chief Executive Officer, received $18,858,968 in total compensation for fiscal 2025.
What was Insulet's say-on-pay result?
The say-on-pay proposal drew 92.0% of votes cast for or against in favor at the meeting held May 20, 2026 for fiscal 2025.
Which companies are in Insulet's peer group?
The disclosed peer group names Align Technology, Inc., Aspen Technology, Inc., Bio-Techne Corporation, DexCom, Inc. and Exact Sciences Corporation, among others.
What is Insulet's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 213:1.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
James Hollingshead
Former President and Chief Executive Officer
◇—◇◇◇—◇◇
Eric Benjamin
Executive Vice President, Chief Operating Officer
◇—◇◇◇—◇◇
John Kapples
Senior Vice President, General Counsel
◇—◇◇◇—◇◇
Mark Field
Former Senior Vice President, Chief Technology Officer
◇—◇◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
James Hollingshead
Former President and Chief Executive Officer
◇—◇◇◇—◇◇
Ana Chadwick
Former Executive Vice President, Former Chief Financial Officer
◇◇◇—◇——◇
Eric Benjamin
Executive Vice President, Chief Operating Officer
◇—◇◇◇—◇◇
Mark Field
Former Senior Vice President, Chief Technology Officer
◇—◇◇◇—◇◇
John Kapples
Senior Vice President, General Counsel
◇—◇◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Ashley McEvoy
President and Chief Executive Officer
◇—◇◇◇—◇◇
James Hollingshead
Former President and Chief Executive Officer
Departed during or after this year
◇—◇◇◇—◇◇
Flavia Pease
Executive Vice President, Chief Financial Officer
◇◇◇◇◇—◇◇
Eric Benjamin
Executive Vice President, Chief Operating Officer
◇—◇◇◇—◇◇
Ana Chadwick
Former Executive Vice President, Former Chief Financial Officer
Departed during or after this year
◇—◇◇◇—◇◇
Mark Field
Former Senior Vice President, Chief Technology Officer
Departed during or after this year
◇—◇◇◇—◇◇
John Kapples
Senior Vice President, General Counsel
◇—◇◇◇—◇◇
Prem Singh
Senior Vice President, Global Operations
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Ana ChadwickPSU◇◇◇◇◇—◇
Ana ChadwickOptions/SARs◇——◇—◇◇
Ana ChadwickRSU◇——◇——◇
Ashley McEvoyRSU◇——◇——◇
Ashley McEvoyPSU◇◇◇◇◇—◇
Ashley McEvoyOptions/SARs◇——◇—◇◇
Eric BenjaminPSU◇◇◇◇◇—◇
Eric BenjaminOptions/SARs◇——◇—◇◇
Eric BenjaminRSU◇——◇——◇
Flavia PeaseOptions/SARs◇——◇—◇◇
Flavia PeaseRSU◇——◇——◇
James HollingsheadOptions/SARs◇——◇—◇◇
James HollingsheadRSU◇——◇——◇
James HollingsheadPSU◇◇◇◇◇—◇
John KapplesRSU◇——◇——◇
John KapplesOptions/SARs◇——◇—◇◇
John KapplesPSU◇◇◇◇◇—◇
Mark FieldPSU◇◇◇◇◇—◇
Mark FieldRSU◇——◇——◇
Mark FieldOptions/SARs◇——◇—◇◇
Prem SinghOptions/SARs◇——◇—◇◇
Prem SinghRSU◇——◇——◇
Prem SinghPSU◇◇◇◇◇—◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
John KapplesOption◇—◇—
Option◇—◇—
PSU◇◇——
PSU◇◇——
PSU◇◇——
Option◇—◇—
RSU◇◇——
RSU◇◇——
PSU◇◇——
Option◇—◇—
RSU◇◇——
RSU◇◇——
Option◇—◇—
Eric BenjaminOption◇—◇—
RSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
Option◇—◇—
PSU◇◇——
Option◇—◇—
Option◇—◇—
Option◇—◇—
RSU◇◇——
RSU◇◇——
Prem SinghOption◇—◇—
Option◇—◇—
PSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
Option◇—◇—
RSU◇◇——
RSU◇◇——
Option◇—◇—
Option◇—◇—
RSU◇◇——
Ashley McEvoyRSU◇◇——
PSU◇◇——
Option◇—◇—
Ana ChadwickPSU◇◇——
Option◇—◇—
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
Flavia PeaseRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇—
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Timothy J. Scannell
◇◇————◇
Wayne A. I. Frederick
◇◇————◇
Elizabeth H. Weatherman
Board chair
◇◇————◇
Timothy C. Stonesifer
◇◇————◇
Luciana Borio
◇◇————◇
Michael R. Minogue
◇◇————◇
Jessica Hopfield
◇◇————◇
Flavia H. Pease
◇◇————◇
Robert L. Huffines
◇◇———◇◇
Ashley A. McEvoy served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Align Technology, Inc. ALGN
  • Aspen Technology, Inc. AZPN
  • Bio-Techne Corporation TECH
  • DexCom, Inc. DXCM
  • Exact Sciences Corporation EXAS
  • Globus Medical, Inc. GMED
  • Guidewire Software, Inc. GWRE
  • Hologic, Inc. HOLX
  • IDEXX Laboratories, Inc. IDXX
  • Masimo Corporation MASI
  • Neurocrine Biosciences, Inc. NBIX
  • NovoCure Limited NVCR
  • ResMed Inc. RMD
  • Teleflex Incorporated TFX

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 20, 2026=◇◇◇
2024May 22, 2025=◇◇◇
2023May 22, 2024=◇◇◇
2022May 23, 2023=◇◇◇
2021May 24, 2022=◇◇◇
2020May 27, 2021=◇◇◇
2019May 29, 2020=◇◇◇
2018May 30, 2019=◇◇◇
2017May 16, 2018=◇◇◇
2016May 17, 2017=◇◇◇
2015May 11, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Insulet files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Insulet disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Insulet sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Insulet's disclosed peer group is defensible, who names Insulet back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
389 figures on this page: 378 cited to the filing that reported them, 11 calculated from figures it prints.
378 cited to the filing
11 calculated from the filing

Documents cited

  1. 0001145197-26-000121
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001140361-26-013333
    2025 Director Compensation Table · 2025 Grants of Plan-Based Awards · CEO Pay Ratio · Fiscal 2025 Summary Compensation Table · and 2 more sections
  3. 0001145197-25-000030
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001140361-25-016308
    Summary Compensation Table
  5. 0001145197-24-000026
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001140361-24-018846
    Summary Compensation Table
  7. 0001145197-23-000042
  8. 0001145197-22-000032
  9. 0001145197-21-000023
  10. 0001145197-20-000017
  11. 0001145197-19-000023
  12. 0001157523-18-001152
  13. 0001157523-17-001624
  14. 0001157523-16-005603
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Insulet executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/PODD (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Insulet and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Insulet discloses

The companies named in PODD's own disclosed peer group.

Align Technology, Inc.Bio-Techne CorporationDexCom, Inc.Globus Medical, Inc.Guidewire Software, Inc.Hologic, Inc.Masimo CorporationNeurocrine Biosciences, Inc.NovoCure LimitedResMed Inc.Teleflex Incorporated

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy